Predictors of hepatorenal syndrome in alcoholic liver cirrhosis

被引:11
|
作者
Janicko, Martin [1 ]
Veseliny, Eduard [1 ]
Senajova, Gabriela [1 ]
Jarcuska, Peter [1 ]
机构
[1] Safarik Univ, Univ Hosp, Dept Internal Med 1, Kosice, Slovakia
来源
BIOMEDICAL PAPERS-OLOMOUC | 2015年 / 159卷 / 04期
关键词
alcohol; liver cirrhosis; hepatorenal syndrome; predictors; SPONTANEOUS BACTERIAL PERITONITIS; RENAL IMPAIRMENT; PROGNOSIS; ASCITES; HYPONATREMIA; MORTALITY; SURVIVAL; IMPROVES; DISEASE;
D O I
10.5507/bp.2015.010
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background. Alcoholic liver disease is a major cause of liver cirrhosis and the hepatorenal syndrome is a serious complication. Risk factors for hepatorenal syndrome (HRS) in alcoholic liver cirrhosis are not entirely explored. Aim. To assess the risk factors for hepatorenal syndrome in alcoholic liver cirrhosis. Patients and Methods. Consecutive patients with alcoholic liver disease were followed for two months, development of renal failure, classified either as HRS or renal failure not fulfilling criteria of HRS, was the main outcome. Results. Of 171 patients, 14 (8.2%) developed HRS and 13 (7.6%), renal failure not fulfilling the HRS criteria. A significant difference was found between patients with and without HRS in serum sodium (131.1 +/- 3.8 vs. 135.7 +/- 5.2; P = 0.003), creatinine, (94.1 +/- 26.8 vs. 80.3 +/- 20.2; P < 0.001), albumin (23.5 +/- 4.9 vs. 29.9 +/- 5.8; P < 0.001), INR (1.76 +/- 0.45 vs. 1.44 +/- 0.41; P < 0.001), bilirubin (252.3 +/- 179.4 vs. 91.2 +/- 101.0; P < 0.001), MELD (23 +/- 6 vs 15 +/- 5; P < 0.001) and MELD-Na score (27 +/- 5 vs. 18 +/- 6; P < 0.001). Multivariate analysis adjusted for sex and age showed that sodium together with creatinine are the strongest HRS predictors, followed by bilirubin with respective odds' ratios (95% CI) of 1.041 (1.012-1.072) for creatinine, 0.870 (0.766-0.988) for serum sodium and 1.005 (1.001-1.010) for serum bilirubin. Conclusion. Serum levels of sodium, creatinine and bilirubin are important predictors of the hepatorenal syndrome.
引用
收藏
页码:661 / 665
页数:5
相关论文
共 50 条
  • [21] DETERMINING OF URINE TRANSAMIDINASE IN LIVER-CIRRHOSIS IN DIAGNOSIS OF HEPATORENAL SYNDROME
    NIKOLAEV, AY
    TERAPEVTICHESKII ARKHIV, 1977, 49 (07) : 101 - 107
  • [22] Diagnostic Significance of Nitrates and Nitrites and L-Arginine, in Development of Hepatorenal Syndrome in Patients with End Stage Alcoholic Liver Cirrhosis
    Nickovic, Vanja
    Kocic, Gordana
    Bjelakovic, Goran
    Pavlovic, Radmila
    Stojanovic, Ivana
    Katanic, Radoslav
    Stojanovic, Svetlana
    Djindjic, Boris
    RENAL FAILURE, 2013, 35 (05) : 633 - 639
  • [23] Hepatorenal syndrome in cirrhosis:: Pathogenesis and treatment
    Arroyo, V
    Guevara, M
    Ginès, P
    GASTROENTEROLOGY, 2002, 122 (06) : 1658 - 1676
  • [24] Circulatory function and hepatorenal syndrome in cirrhosis
    Ruiz-del-Arbol, L
    Monescillo, A
    Arocena, C
    Valer, P
    Ginès, P
    Moreira, V
    Milicua, JM
    Jiménez, W
    Arroyo, V
    HEPATOLOGY, 2005, 42 (02) : 439 - 447
  • [25] Predictors of Response to Therapy with Terlipressin and Albumin in Patients with Cirrhosis and Type 1 Hepatorenal Syndrome
    Nazar, Andre
    Henrique Pereira, Gustavo
    Guevara, Monica
    Martin-Llahi, Marta
    Pepin, Marie-Noelle
    Marinelli, Marcella
    Sola, Elsa
    Eugenia Baccaro, Maria
    Terra, Carlos
    Arroyo, Vicente
    Gines, Pere
    HEPATOLOGY, 2010, 51 (01) : 219 - 226
  • [27] Management of hepatorenal syndrome in patients with cirrhosis
    Arroyo, Vicente
    Fernandez, Javier
    NATURE REVIEWS NEPHROLOGY, 2011, 7 (09) : 517 - 526
  • [28] Management of hepatorenal syndrome in patients with cirrhosis
    Vicente Arroyo
    Javier Fernández
    Nature Reviews Nephrology, 2011, 7 : 517 - 526
  • [29] Ornipressin - A promising option for the treatment of hepatorenal syndrome in liver cirrhosis patients.
    Gunther, R
    Bastian, A
    Folsch, UR
    Schmidt, WE
    GASTROENTEROLOGY, 1997, 112 (04) : A1276 - A1276
  • [30] Outcomes of Patients With Cirrhosis and Hepatorenal Syndrome Type 1 Treated With Liver Transplantation
    Wong, Florence
    Leung, Wesley
    Al Beshir, Mohammed
    Marquez, Max
    Renner, Eberhard L.
    LIVER TRANSPLANTATION, 2015, 21 (03) : 300 - 307